Decision-making on malaria vaccine introduction: the role of cost-effectiveness analysis
- 1 November 2012
- journal article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 90 (11), 864-866
- https://doi.org/10.2471/BLT.12.107482
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa: Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falciparum MalariaValue in Health, 2011
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African ChildrenNew England Journal of Medicine, 2011
- Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisalBMC Medicine, 2011
- Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention StrategiesPLoS Medicine, 2010
- WHO Guide for standardisation of economic evaluations of immunization programmesVaccine, 2010
- Acquired Immunity to MalariaClinical Microbiology Reviews, 2009
- PREDICTIONS OF THE EPIDEMIOLOGIC IMPACT OF INTRODUCING A PRE-ERYTHROCYTIC VACCINE INTO THE EXPANDED PROGRAM ON IMMUNIZATION IN SUB-SAHARAN AFRICAThe American Journal of Tropical Medicine and Hygiene, 2006
- Immune effector mechanisms in malariaParasite Immunology, 2005
- Insecticide-treated bed nets and curtains for preventing malariaCochrane Database of Systematic Reviews, 2004
- COMMUNITY-WIDE EFFECTS OF PERMETHRIN-TREATED BED NETS ON CHILD MORTALITY AND MALARIA MORBIDITY IN WESTERN KENYAThe American Journal of Tropical Medicine and Hygiene, 2003